Table 10.
The distribution of Toxoplasma IgM seropositivity among various hematologic and solid malignancies.
| Cancer type | IgM seropositivity | P value | |
|---|---|---|---|
| Negative | Positive | ||
| Hematologic cancer | |||
| Acute lymphoblastic leukemia | 8 (88.89%) | 1 (11.11%) | |
| Non-Hodgkin lymphoma | 8 (88.89%) | 1 (11.11%) | |
| Hodgkin lymphoma | 5 (71.43%) | 2 (28.57%) | 0.60 |
| Chronic lymphoblastic leukemia | 1 (50.00%) | 1 (50.00%) | |
| Acute myeloid leukemia | 1 (100%) | 0 | |
| Solid cancer | |||
| Breast cancer | 11 (100%) | 0 | |
| Brain cancer | 4 (100%) | 0 | |
| Hepatocellular carcinoma | 4 (100%) | 0 | 0.03 |
| Lung cancer | 1 (50.00%) | 1 (50.00%) | |
| Colon cancer | 1 (100%) | 0 | |
P value was calculated using the Chi square test.
P < 0.05 is statistically significant (in bold).